Allogene Therapeutics
Clinical trials sponsored by Allogene Therapeutics, explained in plain language.
-
New 'Off-the-Shelf' CAR t therapy aims to stop lymphoma from returning
Disease control Recruiting nowThis study is testing whether a new type of 'off-the-shelf' CAR T-cell therapy can help prevent cancer from coming back in adults with large B-cell lymphoma. Participants who have finished their first round of treatment and have only tiny amounts of cancer cells left are randomly…
Phase: PHASE2 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists test 'Living Drug' to reset the immune system in lupus and related diseases
Disease control Recruiting nowThis is a first-in-human study testing the safety and early effectiveness of a new type of cell therapy called ALLO-329 in adults with severe autoimmune diseases like lupus, myositis, and scleroderma. The therapy involves giving patients specially engineered immune cells (CAR T c…
Phase: PHASE1 • Sponsor: Allogene Therapeutics • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC